HYDERABAD, India, Dec 24 () - Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year. Novo's strategy emphasizes price cuts and accelerated launches, while Lilly's products benefitted from hitting the market early.

"The sheer amount of radiated energy from these bursts is so large that you can't power them with a core collapse stellar explosion — or any other type of normal stellar explosion."

While arranging a family get-away, picking the right convenience is fundamental to guarantee solace, comfort, and delight for everybody. Unique

By blaming chronic disease and disability on food and toxins, and ‘just asking questions’ about widely accepted science, MAHA discounts the government’s responsibility for meeting disabled peoples’ needs.

A vocation change can be an overwhelming and life changing choice. It frequently includes abandoning the recognizable and wandering into

The World Health Organization issued new guidelines recommending the use of GLP-1 drugs for adults with obesity and called for action on manufacturing and affordability.

New research shows how identity-driven assumptions can turn common ground into conflict.

Who could forget about the engagement between "your English teacher and your gym teacher" that broke the internet? Or the fictional love triangle between siblings that consumed our summer nights?